As a consequence, it is conceivable that although both vitamin D and IL-33 in the bone environment exert protective effects against OP, in inflamed Pso skin and in PsoA, the deleterious effects of vitamin D deficiency and IL-33/ST2 axis activation potentiate each other (85, 100). The gene discussed is IL33; the disease is vitamin D deficiency.